Ionis Pharmaceuticals Inc. Stock
Ionis Pharmaceuticals Inc. shows a slight decrease today, losing -€0.130 (-0.330%) compared to yesterday.
Our community is currently high on Ionis Pharmaceuticals Inc. with 17 Buy predictions and 5 Sell predictions.
With a target price of 56 € there is a positive potential of 43.04% for Ionis Pharmaceuticals Inc. compared to the current price of 39.15 €.
Our community identified positive and negative aspects for Ionis Pharmaceuticals Inc. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Ionis Pharmaceuticals Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Ionis Pharmaceuticals Inc. in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ionis Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ionis Pharmaceuticals Inc. | -0.330% | 0.306% | -1.579% | 24.936% | -13.992% | 26.955% | -39.616% |
| Ironwood Pharmaceuticals | -2.630% | 2.778% | -1.333% | -23.711% | -27.451% | -13.450% | - |
| Sage Therapeutics Inc. | -4.710% | -6.913% | -18.653% | -69.951% | -38.400% | -79.398% | - |
| Novocure Ltd | 0.690% | 20.929% | 13.920% | -76.163% | 1.191% | -90.992% | - |
Comments
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $58.00 price target on the stock.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "outperform" rating re-affirmed by analysts at William Blair.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.
Show more
Ratings data for IONS provided by MarketBeat